LY3154207
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for LY3154207, covering 2015-06-11 to 2021-07-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) [Phase 2]